171 related articles for article (PubMed ID: 17702862)
1. Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia.
Kovacs A; Tornvall P; Nilsson R; Tegnér J; Hamsten A; Björkegren J
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13768-73. PubMed ID: 17702862
[TBL] [Abstract][Full Text] [Related]
2. No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice.
Torzewski M; Reifenberg K; Cheng F; Wiese E; Küpper I; Crain J; Lackner KJ; Bhakdi S
Thromb Haemost; 2008 Jan; 99(1):196-201. PubMed ID: 18217154
[TBL] [Abstract][Full Text] [Related]
3. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia.
Heinonen SE; Leppänen P; Kholová I; Lumivuori H; Häkkinen SK; Bosch F; Laakso M; Ylä-Herttuala S
Circ Res; 2007 Nov; 101(10):1058-67. PubMed ID: 17872464
[TBL] [Abstract][Full Text] [Related]
4. No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.
Trion A; de Maat MP; Jukema JW; van der Laarse A; Maas MC; Offerman EH; Havekes LM; Szalai AJ; Princen HM; Emeis JJ
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1635-40. PubMed ID: 15920036
[TBL] [Abstract][Full Text] [Related]
5. Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?
Reifenberg K; Lehr HA; Baskal D; Wiese E; Schaefer SC; Black S; Samols D; Torzewski M; Lackner KJ; Husmann M; Blettner M; Bhakdi S
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1641-6. PubMed ID: 15920030
[TBL] [Abstract][Full Text] [Related]
6. Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice.
Schwedler SB; Amann K; Wernicke K; Krebs A; Nauck M; Wanner C; Potempa LA; Galle J
Circulation; 2005 Aug; 112(7):1016-23. PubMed ID: 16087790
[TBL] [Abstract][Full Text] [Related]
7. Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice.
Ortiz MA; Campana GL; Woods JR; Boguslawski G; Sosa MJ; Walker CL; Labarrere CA
Exp Biol Med (Maywood); 2009 Jun; 234(6):624-31. PubMed ID: 19359657
[TBL] [Abstract][Full Text] [Related]
8. Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoprotein-receptor/apolipoprotein B48-deficient mice.
Leppänen P; Koota S; Kholová I; Koponen J; Fieber C; Eriksson U; Alitalo K; Ylä-Herttuala S
Circulation; 2005 Aug; 112(9):1347-52. PubMed ID: 16129816
[TBL] [Abstract][Full Text] [Related]
9. Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice.
Bro S; Borup R; Andersen CB; Moeller F; Olgaard K; Nielsen LB
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):570-5. PubMed ID: 16373611
[TBL] [Abstract][Full Text] [Related]
10. Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life.
Alkemade FE; Gittenberger-de Groot AC; Schiel AE; VanMunsteren JC; Hogers B; van Vliet LS; Poelmann RE; Havekes LM; Willems van Dijk K; DeRuiter MC
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2228-35. PubMed ID: 17656671
[TBL] [Abstract][Full Text] [Related]
11. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
[TBL] [Abstract][Full Text] [Related]
12. MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr(-/-)Apob(100/100) mouse.
Wågsäter D; Zhu C; Björkegren J; Skogsberg J; Eriksson P
Int J Mol Med; 2011 Aug; 28(2):247-53. PubMed ID: 21567073
[TBL] [Abstract][Full Text] [Related]
13. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
Desai A; Zhao Y; Warren JS
Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
[TBL] [Abstract][Full Text] [Related]
14. Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.
Hirschfield GM; Gallimore JR; Kahan MC; Hutchinson WL; Sabin CA; Benson GM; Dhillon AP; Tennent GA; Pepys MB
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8309-14. PubMed ID: 15919817
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis.
Norata GD; Marchesi P; Pulakazhi Venu VK; Pasqualini F; Anselmo A; Moalli F; Pizzitola I; Garlanda C; Mantovani A; Catapano AL
Circulation; 2009 Aug; 120(8):699-708. PubMed ID: 19667236
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice.
Westerterp M; Berbée JF; Pires NM; van Mierlo GJ; Kleemann R; Romijn JA; Havekes LM; Rensen PC
Circulation; 2007 Nov; 116(19):2173-81. PubMed ID: 17967778
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice.
Matthijsen RA; de Winther MP; Kuipers D; van der Made I; Weber C; Herias MV; Gijbels MJ; Buurman WA
Circulation; 2009 Apr; 119(16):2188-95. PubMed ID: 19380618
[TBL] [Abstract][Full Text] [Related]
18. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
19. Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes.
Collins AR; Lyon CJ; Xia X; Liu JZ; Tangirala RK; Yin F; Boyadjian R; Bikineyeva A; Praticò D; Harrison DG; Hsueh WA
Circ Res; 2009 Mar; 104(6):e42-54. PubMed ID: 19265038
[TBL] [Abstract][Full Text] [Related]
20. CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice.
Olofsson PS; Söderström LA; Wågsäter D; Sheikine Y; Ocaya P; Lang F; Rabu C; Chen L; Rudling M; Aukrust P; Hedin U; Paulsson-Berne G; Sirsjö A; Hansson GK
Circulation; 2008 Mar; 117(10):1292-301. PubMed ID: 18285570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
